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Background -A study was undertaken to determine the proportion of patients with potentially operable non-small cell lung cancer that could be spared thoracotomy by a systematic search for extrathoracic metastases. Methods -An English language literature search was carried out using MEDLINE and bibliographic reviews of textbooks, review articles, and key articles. Studies were included in which at least 90% of the patients had histologically proven non-small cell cancer of the lung, were presumed otherwise operable, and for which the results of computed tomography of the head or abdomen, ultrasonography of the abdomen, or radionuclide imaging (scan) of bone or liver were available. Study quality and specific descriptive information concerning population, intervention, and outcome measurements were assessed.
Results -Of approximately 1500 citations which were screened, 100 were reviewed in detail and data abstracted from 16. The number of patients (total number, followed in square brackets by number of asymptomatic patients) shown to be inoperable directly as a result of the investigation and thus spared unnecessary thoracotomy was: computed tomography of the head: 26/785 (3 3%), 95% confidence interval (CI) 2 All data were abstracted in duplicate. Summaries of the data and of assessments of methodological quality were sent to the principal investigators for verification. Corrections were made on the basis of information from the authors.
STATISTICAL METHODS
Observer agreement was calculated using the kappa statistic.'9 For all proportions, 95% confidence intervals (CI) were calculated. Chi square tests (X2) were used to determine if proportions differed in the different studies. If the x2 test was positive, suggesting heterogeneity, a further analysis to determine whether the difference could be explained by variations in methodological quality was undertaken. Studies were divided into the three grades of quality and a x2 test was conducted to determine whether there were differences in the proportion of metastases detected within the three grades.
Results
Approximately 1500 citations were reviewed of which 100 met initial inclusion criteria. The kappa value on the random sample of 70 citations was 0-74 (95% CI 0-63 to 0 85). The kappa value for the relevance rating on the 100 papers which were retrieved was 0-72 (95% CI 0 62 to 0-82). Of the original 100 papers 16 were ultimately judged to be relevant. '5 162033 Several of the more frequently cited papers5 18 were excluded because more than 10% of the population had small cell carcinoma and the results for these patients were not separated from those of the remainder.
BRAIN
Nine papers'5 16 1/77 Hx = history; Px = physical examination; CT = computed tomography. -= paper does not include this group; ? = unable to extract these data from paper. the abdomen was described and reproducible 20 2230-32 in five of the papers. based on all studies. The row labelled "Clinic" represents the yields when analysis was based upon studies in which patients were presumed operable after preoperative examination which did not include a CT scan of the thorax. The row labelled "CT" below each organ system represents the yields when analysis was limited to studies that included only patients who were presumed resectable after having a CT scan of the thorax for metastases to the brain,213132 adrenal glands, 2' bone,213233 and liver.3132
COMPLICATIONS OF INVESTIGATIONS
In determining the efficacy of the investigations, harmful side effects or complications must be assessed. 
Discussion
The limitations of this overview include the fact that no attempt was made to identify unpublished literature or non-English language papers, nor were those assessing the relevance or methodological quality of the articles or abstracting the data blinded to the setting of the trial or the results. Most of the methodological criteria for conducting a scientific overview were, however, satisfied.3435
To determine whether imaging procedures should be undertaken, a precise estimate of the number of patients with metastatic disease spared thoracotomy in each relevant subgroup is required. Additional important information should include the complications of the imaging procedures themselves and any invasive procedures that resulted, the resulting delay in surgery, and the economic consequences (including resources expended through additional imaging and saved through avoiding thoracotomies without cure).
Our overview reveals that, despite the large amount of literature in this area, most studies suffer from severe methodological limitations. Our approach to obtaining the best available answers to the questions we posed was to combine data from different studies. In cases where the results of the studies are very different (suggesting important differences in the population studied, the way the tests were conducted, or the results followed up) this approach could be questioned. For brain and liver scanning similar results were obtained and formal tests for heterogeneity were negative. For adrenal scanning the results differed substantially and a formal test for homogeneity was significant (p < 0 005). In this instance, differences in results may be (at least in part) explained by the methodological quality of the investigations. Higher quality studies yielded a larger number of positive test results (p <005). Thus, the estimates of the yield of adrenal scanning in tables 2 and 5, based on all studies, may represent underestimates of the yield of the procedure.
The other instance in which results differed substantially and the test for heterogeneity was positive (p<0 01) was bone scanning. Here differences cannot be explained by methodological quality. The number of thoracotomies saved by bone scanning varied from 0 of 5128 to 10 of 53.27 The differences may be explained by selection of patients and criteria for a true positive bone scan. Ramsdell et a128 excluded all patients with "obvious metastatic disease." Several of the patients with positive bone scanning in the study by Quinn et aF had N2 disease; it is possible that such patients may have been excluded from the study by Ramsdell et al. Similarly, the criterion for a true positive scan in the study by Quinn et al was "abnormalities that were not proved benign by additional studies." Ramsdell et al included three patients in whom scan results suggested metastases that were excluded by lack of progression over 12 months in one and necropsy findings in two others. It is possible that findings in such patients may have been classified as positive by Quinn et al. Similar factors may explain the smaller differences found in the other studies.
With respect to relevant subgroups, many studies have not separated those with organspecific symptoms, systemic symptoms, or no symptoms when reporting the number of true positive imaging procedures. Even when subgroups were specified, detailed criteria that would allow replication of the classification of subjects were not provided. To cite a single example: would a patient with moderate but unchanging weekly headaches for the previous year be classified as having organ-specific neurological symptoms suggestive of metastatic disease to the brain? Because the number of subjects available is small, the confidence intervals around the number of thoracotomies without cure that are avoided by each test are wide.
The "CT" column in table 5 points out how the number of patients identified with metastatic disease after a CT scan of the thorax is reduced, when compared with those studies in which the initial examination was limited to history taking and physical examination, with or without radiography and plain tomography. Presumably many of the patients with occult metastatic disease in the latter group of studies also had occult mediastinal disease and would be excluded from surgery on this basis. The small number of subjects available results in large confidence intervals, particularly for asymptomatic patients, in those who underwent CT scanning. Indeed, despite the trend towards lower numbers of patients found with metastatic disease and asymptomatic disease after a CT scan of the thorax, these findings did not reach statistical significance (x2= 5-44, p=O007; X2=0712, p=O07). This precludes firm conclusions being made about the number of asymptomatic patients saved a thoracotomy in this subset of studies.
Complications of testing or of invasive procedures as a result of testing were poorly documented in the available studies.
Despite the limitations of this overview, the data from the primary studies do permit certain restricted conclusions. They support the current practice of investigating a particular organ system if there are symptoms or signs suggestive of metastatic disease. For brain and bone imaging, the data suggest that investigation is appropriate for patients without organspecific symptoms, but with systemic symptoms.
The data cannot resolve the most controversial topic -namely, the investigation of the asymptomatic patient. For each test the upper limits of the confidence intervals around the proportion of patients spared futile thoracotomy include values which would mandate investigation of all patients. However, lower limits of the confidence intervals, if representing the true proportion, would support the current practice of proceeding directly to thoracotomy in asymptomatic patients. A study with a large sample size, standardised initial examinations, preferably including thoracic CT, and documentation of the complications and economic consequences of testing is required to narrow these confidence intervals and provide information missing from current studies. Nevertheless, these data provide support for a policy of carefully considering whether in each individual case a patient with potentially operable non-small cell carcinoma of the lung should have a full investigation for metastatic disease to minimise the risk of an inappropriate thoracotomy.
